{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Fajardo",
      "address_1": "Road 195, Km 1.1",
      "reason_for_recall": "Failed Impurity/Degradation Specifications due to moisture ingress in individual bottles",
      "address_2": "Union Street",
      "product_quantity": "3155 bottles",
      "code_info": "0.45 mg: 505969A",
      "center_classification_date": "20130131",
      "distribution_pattern": "US Nationwide",
      "state": "PR",
      "product_description": "Femtrace 0.45 mg (Estradiol Acetate) Tablets, Rx Only, 100 tablets, Manufactured by Pharmaceutics International Inc, Hunt Valley, MD 21031 for Warner Chilcott Company LLC, Fajardo, PR 00738",
      "report_date": "20130206",
      "classification": "Class III",
      "openfda": {},
      "recalling_firm": "Warner Chilcott Company LLC",
      "recall_number": "D-142-2013",
      "initial_firm_notification": "Letter",
      "product_type": "Drugs",
      "event_id": "64014",
      "termination_date": "20150616",
      "more_code_info": "",
      "recall_initiation_date": "20121221",
      "postal_code": "00738",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}